10 Best Pot Stocks To Invest In According to Analysts

5. Cresco Labs (OTC:CRLBF)

Share Price (As of December 23): $0.90

Analyst Upside: 125.26%

Cresco Labs (OTC:CRLBF) is a multi-state cannabis company with operations in the retail and medical cannabis segment. The company is licensed to grow, manufacture, and sell retail and medical cannabis products primarily through Sunnyside, Cresco Labs’ national dispensary brand, and third-party retail stores. The company offers more than 400 products sold across 1,600 dispensaries and retail stores in the US.

Cresco Labs (OTC:CRLBF) is focused on specific market segments where it has a stronghold and significant growth potential. In addition, the company is focused on best-in-class retail operations. This policy has recently been a key driver for the company’s growth. During the third quarter of 2024, the company recorded revenue of $180 million at a 29% adjusted EBITDA margin.

The key thing was the company posted its record $49 million of operating cash flow during Q3. In 2024 so far, Cresco Labs had $103 million in operating cash flow, allowing the company to reinvest in its core business and explore new markets.